NCT00804115View on ClinicalTrials.gov

The International Collaborative Exfoliation Syndrome Treatment Study

NAUnknownINTERVENTIONAL

Enrollment

277

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2008

Conditions

Exfoliation SyndromeGlaucomaOcular Hypertension

Interventions

DRUG

Latanoprost with Pilocarpine vs Timolol or Cosopt

Timolol 0.5% bid or Cosopt bid Latanoprost 0.005% qhs Pilocarpine 2%

Trial Locations (1)

10003

New York Eye and Ear Infirmary, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

The New York Eye & Ear Infirmary

OTHER